Anthem (NASDAQ:ANTX – Get Free Report) is one of 226 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its rivals? We will compare Anthem to similar businesses based on the strength of its risk, analyst recommendations, valuation, institutional ownership, dividends, earnings and profitability.
Insider & Institutional Ownership
90.5% of Anthem shares are held by institutional investors. Comparatively, 32.4% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 24.5% of Anthem shares are held by company insiders. Comparatively, 14.5% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Anthem and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Anthem | N/A | -$35.17 million | -3.12 |
| Anthem Competitors | $324.59 million | -$27.58 million | -4.53 |
Volatility and Risk
Anthem has a beta of -1.31, meaning that its stock price is 231% less volatile than the S&P 500. Comparatively, Anthem’s rivals have a beta of 11.77, meaning that their average stock price is 1,077% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Anthem and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Anthem | 1 | 0 | 1 | 0 | 2.00 |
| Anthem Competitors | 2263 | 2494 | 4571 | 71 | 2.26 |
Anthem currently has a consensus price target of $2.00, suggesting a potential downside of 44.75%. As a group, “Pharmaceutical preparations” companies have a potential upside of 125.84%. Given Anthem’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Anthem has less favorable growth aspects than its rivals.
Profitability
This table compares Anthem and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Anthem | N/A | -55.04% | -49.13% |
| Anthem Competitors | -4,724.33% | -252.77% | -49.42% |
Summary
Anthem beats its rivals on 7 of the 13 factors compared.
About Anthem
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.
